| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BRKR | Common Stock | Sale | -$11.8M | -146K | -0.38% | $81.01 | 38.4M | Apr 24, 2023 | Direct | F1, F2 |
| transaction | BRKR | Common Stock | Sale | -$172K | -2.11K | -0.01% | $81.65 | 38.3M | Apr 24, 2023 | Direct | F1, F3 |
| transaction | BRKR | Common Stock | Sale | -$1.07M | -13.8K | -0.04% | $77.87 | 38.3M | Apr 25, 2023 | Direct | F1, F4 |
| transaction | BRKR | Common Stock | Sale | -$2.4M | -30.3K | -0.08% | $79.06 | 38.3M | Apr 25, 2023 | Direct | F1, F5 |
| transaction | BRKR | Common Stock | Sale | -$573K | -7.17K | -0.02% | $79.82 | 38.3M | Apr 25, 2023 | Direct | F1, F6 |
| transaction | BRKR | Common Stock | Sale | -$37.1K | -460 | 0% | $80.64 | 38.3M | Apr 25, 2023 | Direct | F1, F7 |
| holding | BRKR | Common Stock | 1.05M | Apr 24, 2023 | By Former Spouse | F8 | |||||
| holding | BRKR | Common Stock | 337K | Apr 24, 2023 | By Son | F8 | |||||
| holding | BRKR | Common Stock | 337K | Apr 24, 2023 | By Daughter | F8 | |||||
| holding | BRKR | Common Stock | 202K | Apr 24, 2023 | As UTMA Custodian for Son | ||||||
| holding | BRKR | Common Stock | 71.7K | Apr 24, 2023 | As UTMA Custodian for Son | ||||||
| holding | BRKR | Common Stock | 492 | Apr 24, 2023 | By Former Spouse | F8 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The shares represented by this transaction were sold pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.57 to $81.52, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.585 to $81.93, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.51 to $78.45, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.515 to $79.50, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.51 to $80.35, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.58 to $80.67, inclusive. The Reporting Person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | The Reporting Person disclaims beneficial ownership of 1,046,499 shares held by the Reporting Person's former spouse- Robyn Laukien, 492 shares held by the Reporting Person's former spouse- Ruta Laukien, 337,087 shares held by the Reporting Person's adult son and 336,607 shares held by the Reporting Person's adult daughter, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |